Abstract
Hodgkin lymphoma is lymphoid neoplasm in which the malignant cells admixed with a heterogeneous population of non-neoplastic inflammatory cells. A combination of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) is the most commonly used chemotherapy regime for Hodgkin lymphoma. In this case report, we present a patient with Hodgkin lymphoma who developed bilateral auricular hematoma after a first time administrition of ABVD treatment. A 27-year-old female patient was presented to the hematology outpatient clinic with a swelling in the neck for two weeks. An excisional biopsy performed from the left axillary region. The pathology report demonstrated classical Hodgkin lymphoma was noticed to be consistent with mixed cellular type. First dose ABVD protocol was administered to the patient. One week after chemotherapy, swelling and discoloration were observed in the patient's bilateral auricles without a history of trauma. The patient was consulted to the Department of Otorhinolarngology-Head and Neck Surgery. Bilateral drainage of auricular hematoma was performed immediately. Intravenous ciprofloxacin was also administered. The auricular hematoma did not reoccur after the subsequent chemotherapy treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
